A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancer (Q45076471)

From Wikidata
Jump to navigation Jump to search
scientific article published in February 2005
edit
Language Label Description Also known as
English
A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancer
scientific article published in February 2005

    Statements

    A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit